You have not yet given permission to place the required cookies. Accept the required cookies to view this content.
4270
Expert views
October 30, 2024
Using Pandemic Mortality Experience for Pricing Longevity
News
October 25, 2024
Winner of the 2024 Most Innovative Product/Service Award - General Insurance
Our experts
Julien joined SCOR Alternative Solutions in 2022, as an underwriter, working for corporates clients in the EMEA region, and also contributing to the advisory, analytics within the team.
Our experts
Roshan is a longevity specialist with more than 10 years of experience in the field.
L&H
campus
- Review of neurological, developmental, and mental health conditions
L&H
campus
Drugs developed for the treatment of diabetes such as semaglutide (marketed as Ozempic or Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro or Zepbound) are being used to decrease the weight of obesity risks:
Press Releases
2024 L&H assumption review completed, Group solvency ratio of 203%
